Last updated: 5 August 2024 at 6:33pm EST

Dr. Hazel Hunt Ph.D. Net Worth




The estimated Net Worth of Hazel Hunt is at least 6.91 百万$ dollars as of 1 August 2024. Dr Hunt owns over 60,000 units of Corcept Therapeutics Inc stock worth over 5,451,735$ and over the last 4 years he sold CORT stock worth over 631,855$. In addition, he makes 826,667$ as Chief Scientific Officer at Corcept Therapeutics Inc.

Dr D CORT stock SEC Form 4 insiders trading

Dr has made over 8 trades of the Corcept Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 60,000 units of CORT stock worth 168,600$ on 1 August 2024.

The largest trade he's ever made was exercising 60,000 units of Corcept Therapeutics Inc stock on 1 August 2024 worth over 168,600$. On average, Dr trades about 28,497 units every 104 days since 2020. As of 1 August 2024 he still owns at least 153,354 units of Corcept Therapeutics Inc stock.

You can see the complete history of Dr Hunt stock trades at the bottom of the page.





Dr. Hazel Hunt Ph.D. biography

Dr. Hazel Hunt Ph.D. is the Chief Scientific Officer at Corcept Therapeutics Inc.

What is the salary of Dr D?

As the Chief Scientific Officer of Corcept Therapeutics Inc, the total compensation of Dr D at Corcept Therapeutics Inc is 826,667$. There are 6 executives at Corcept Therapeutics Inc getting paid more, with Joseph Belanoff having the highest compensation of 4,958,970$.



How old is Dr D?

Dr D is 61, he's been the Chief Scientific Officer of Corcept Therapeutics Inc since . There are 6 older and 12 younger executives at Corcept Therapeutics Inc. The oldest executive at Corcept Therapeutics Inc is George Baker, 77, who is the Independent Director.

What's Dr D's mailing address?

Hazel's mailing address filed with the SEC is C/O CORCEPT THERAPEUTICS INCORPORATED, 101 REDWOOD SHORES PARKWAY, REDWOOD CITY, CA, 94065.

Insiders trading at Corcept Therapeutics Inc

Over the last 21 years, insiders at Corcept Therapeutics Inc have traded over 107,318,493$ worth of Corcept Therapeutics Inc stock and bought 71,912,273 units worth 127,133,071$ . The most active insiders traders include Patrick G EnrightAllen AnderssonVentures, Llc Paperboy. On average, Corcept Therapeutics Inc executives and independent directors trade stock every 14 days with the average trade being worth of 8,010,233$. The most recent stock trade was executed by William Guyer on 3 September 2024, trading 10,000 units of CORT stock currently worth 216,500$.



What does Corcept Therapeutics Inc do?

leading the field in the discovery of drugs that modulate the effects of cortisol the adverse effects of excess cortisol have been corcept’s focus since the company’s inception. abnormal levels and release of cortisol play a role in a variety of metabolic, oncological, and psychiatric diseases, and we are currently studying a new generation of compounds that may mitigate the effects of excess cortisol. in addition to our work with mifepristone, we have developed over 300 proprietary molecules, advancing the most promising of these to the clinic to see if they can mitigate the effects of excess cortisol and the serious, sometimes life-threatening conditions that may result. all of these compounds competitively block the glucocorticoid receptor (gr), but not the progesterone receptor. scientific literature suggests that competitive gr antagonism may have a role in treating many conditions, including post-traumatic stress disorder, mild cognitive impairment, alzheimer’s disease, alcoholis



Complete history of Dr Hunt stock trades at Corcept Therapeutics Inc

インサイダー
取引
取引
合計金額
Hazel Hunt
Chief Scientific Officer
オプション行使 168,600$
1 Aug 2024
Hazel Hunt
Chief Scientific Officer
オプション行使 151,000$
8 Jan 2024
Hazel Hunt
Chief Scientific Officer
販売 631,855$
14 Aug 2023
Hazel Hunt
Chief Scientific Officer
オプション行使 151,000$
8 Aug 2023
Hazel Hunt
Chief Scientific Officer
オプション行使 104,000$
28 Sep 2022
Hazel Hunt
Chief Scientific Officer
オプション行使 132,800$
26 Jan 2022
Hazel Hunt
Chief Scientific Officer
オプション行使 144,500$
14 Jul 2021
Hazel Hunt
Chief Scientific Officer
オプション行使 198,000$
24 Nov 2020


Corcept Therapeutics Inc executives and stock owners

Corcept Therapeutics Inc executives and other stock owners filed with the SEC include: